News

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.
A blood test that can detect cancer before symptoms develop is being assessed for potential NHS use, health officials have ...
Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...
India's reference dataset for genetics and genomics -- could help improve how disease is diagnosed, predict one's response to ...
Under Reshma Kewalramani's leadership, Vertex achieved a major milestone with the FDA’s first-ever approval of a CRISPR-based ...
Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC ...
North Carolina is listed as a location for the manufacture of AstraZeneca and Sanofi's respiratory syncytial virus (RSV) prevention antibody, nirsevimab, as well as for GSK's two-drug HIV regimen ...
The Belgian Federal Public Service of Justice on Monday confirmed that fugitive Indian businessman Mehul Choksi was arrested on April 12.
Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...
They have produced a steady stream of scientific breakthroughs and skilled young graduates who flow into companies pursuing ...